Land: Israël
Taal: Engels
Bron: Ministry of Health
EZETIMIBE; SIMVASTATIN
MERCK SHARP & DOHME ISRAEL LTD
C10AA01
TABLETS
SIMVASTATIN 20 MG; EZETIMIBE 10 MG
PER OS
Required
MERCK SHARP & DOHME B.V., THE NETHERLANDS
SIMVASTATIN
SIMVASTATIN
Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH.Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).
2012-04-30